Studies suggest that individuals with type 2 diabetes often have lower magnesium levels compared to those without diabetes
Many of my clients struggle to eat enough food overall, let alone focus on protein
I chose to publish rather than stay quiet because GLP-1 use among age-group endurance athletes is far more common than public conversation suggests
You pick your provider from a named list with availability shown up front
Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT trial)
Microdosing Tirzepatide Long-term metabolic support, greater comfort MEDICATION GLP-1 + GIP (Tirzepatide) Low Dose IDEAL FOR Individuals seeking metabolic support with greater comfort and control What to expect Subtle, sustainable support with improved tolerability Included Care Provider care + labs + lifestyle coaching Check Eligibility GLP-1 Elite Maximum support for challenging plateaus MEDICATION Dual GLP-1 + GIP (Semaglutide + Tirzepatide) IDEAL FOR Plateaued patients currently on semaglutide or tirzepatide What to expect Enhanced support when progress has slowed Included Care Provider care + labs + lifestyle coaching Check Eligibility GLP-1 Advanced Stronger appetite control, faster momentum MEDICATION GLP-1 + GIP (Tirzepatide) IDEAL FOR Stronger appetite suppression or added glucose control What to expect Faster progress than Core, steadier momentum Included Care Provider care + labs + lifestyle coaching Check Eligibility GLP-1 Core Steady, foundational weight loss MEDICATION GLP-1 (Semaglutide) IDEAL FOR First-time users or moderate goals What to expect Gradual, consistent progress Included Care Provider care + labs + lifestyle coaching Check Eligibility The science behind GLP-1 How GLP-1 signaling supports appetite regulation and healthier glucose response
